These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28526814)

  • 21. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
    Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
    Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
    Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital.
    Yazawa R; Yazawa H; Fukuda K; Ohara M; Osuka F
    Fukushima J Med Sci; 2023 Apr; 69(1):57-65. PubMed ID: 36990788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review.
    Stein A; Strong E; Clark Gamblin T; Clarke C; Tsai S; Thomas J; George B; Mogal H
    Ann Surg Oncol; 2020 Jan; 27(1):85-97. PubMed ID: 31583543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.
    Munari G; Businello G; Mattiolo P; Pennelli G; Sbaraglia M; Borga C; Pucciarelli S; Spolverato G; Mescoli C; Galuppini F; Sommariva A; Bellan E; Lonardi S; Loupakis F; Luchini C; Dei Tos AP; Fassan M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1897-1904. PubMed ID: 33712927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
    Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
    Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward the molecular dissection of peritoneal pseudomyxoma.
    Pietrantonio F; Perrone F; Mennitto A; Gleeson EM; Milione M; Tamborini E; Busico A; Settanni G; Berenato R; Caporale M; Morano F; Bossi I; Pellegrinelli A; Di Bartolomeo M; de Braud F; Baratti D; Bowne WB; Kusamura S; Deraco M
    Ann Oncol; 2016 Nov; 27(11):2097-2103. PubMed ID: 27502722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
    Guaglio M; Sinukumar S; Kusamura S; Milione M; Pietrantonio F; Battaglia L; Guadagni S; Baratti D; Deraco M
    Ann Surg Oncol; 2018 Apr; 25(4):878-884. PubMed ID: 29270877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GNAS mutations are associated with mucin production in low-grade appendiceal mucinous neoplasms, villous adenomas, and carcinomas.
    Zauber P; Marotta S; Sabbath-Solitare M
    Hum Pathol; 2015 Feb; 46(2):339. PubMed ID: 25466964
    [No Abstract]   [Full Text] [Related]  

  • 31. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
    Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
    Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appendiceal sessile serrated lesions are distinct from their right-sided colonic counterparts and may be precursors for appendiceal mucinous neoplasms.
    Chezar K; Minoo P
    Hum Pathol; 2022 Apr; 122():40-49. PubMed ID: 35121004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of appendectomy for mucinous ovarian neoplasms.
    Lin JE; Seo S; Kushner DM; Rose SL
    Am J Obstet Gynecol; 2013 Jan; 208(1):46.e1-4. PubMed ID: 23117124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mucinous adenocarcinoma of the appendix associated with ovarian tumors and pseudomyxoma peritonei. The difficulty in differential diagnosis].
    Ciriza C; Valerdiz S; Toribio C; Dajil S; Romero MJ; Urquiza O; Karpman G
    An Med Interna; 2000 Oct; 17(10):540-2. PubMed ID: 11109650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases.
    Seidman JD; Elsayed AM; Sobin LH; Tavassoli FA
    Am J Surg Pathol; 1993 Jan; 17(1):22-34. PubMed ID: 8383467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk.
    Hegg KS; Mack LA; Bouchard-Fortier A; Temple WJ; Gui X
    Ann Diagn Pathol; 2020 Oct; 48():151606. PubMed ID: 32889392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRAS Mutations With No GNAS Mutations in an Intraductal Papillary Mucinous Neoplasm: Are There Common Pathways With Pancreatic Ductal Adenocarcinoma? Lessons From an Extended IPMN, Covering the Entire Pancreas.
    Tampakis A; Tampaki EC; Posabella A; Zettl A; Kouraklis G; von Flüe M; Guenin MO
    Pancreas; 2017 Jan; 46(1):e5-e7. PubMed ID: 27977634
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ovarian mucinous adenocarcinoma, mucocele of the appendix and pseudomyxoma peritonei: case report with immunohistochemical analysis].
    Singh A; Winkler M; Handt S; Rath W
    Zentralbl Gynakol; 2000; 122(3):175-8. PubMed ID: 10756603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.